Page last updated: 2024-11-08

cantharidin and Leukemia L 1210

cantharidin has been researched along with Leukemia L 1210 in 2 studies

Cantharidin: A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally.
cantharidin : A monoterpenoid with an epoxy-bridged cyclic dicarboxylic anhydride structure secreted by many species of blister beetle, and most notably by the Spanish fly, Lytta vesicatoria. Natural toxin inhibitor of protein phosphatases 1 and 2A.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, MC1
Tsai, ET1
Wu, JY1
Liao, HF1
Chen, YJ1
Kuo, CD1
McCluskey, A1
Ackland, SP1
Bowyer, MC1
Baldwin, ML1
Garner, J1
Walkom, CC1
Sakoff, JA1

Other Studies

2 other studies available for cantharidin and Leukemia L 1210

ArticleYear
N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model.
    Anti-cancer drugs, 2015, Volume: 26, Issue:5

    Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Cantharidin; Cell Cycle; Cell Line, Tumor; Ce

2015
Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
    Bioorganic chemistry, 2003, Volume: 31, Issue:1

    Topics: Animals; Antineoplastic Agents; Cantharidin; Cell Division; Cell Line, Tumor; Drug Screening Assays,

2003